European Markets Valneva’s Bleak Q1: Revenue Halved, Net Loss Tripled, and the Only Lifeline Is a Lyme Vaccine Filing Due This Autumn
Valneva’s share price closed at €2.33 on Friday, just nine percent above its 52-week low of €2.13 and more than half below the August high. The stock has now surrendered...